688739 Stock Overview
A biotechnology company, engages in the research and development, production, and sales of vaccines for human use in China.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Liaoning Chengda Biotechnology Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥22.55 |
52 Week High | CN¥35.24 |
52 Week Low | CN¥21.95 |
Beta | 0.59 |
11 Month Change | -2.47% |
3 Month Change | -10.66% |
1 Year Change | -33.56% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -71.81% |
Recent News & Updates
Liaoning Chengda Biotechnology Co.,Ltd.'s (SHSE:688739) Price Is Right But Growth Is Lacking
Aug 22Some May Be Optimistic About Liaoning Chengda BiotechnologyLtd's (SHSE:688739) Earnings
Apr 29Recent updates
Shareholder Returns
688739 | CN Biotechs | CN Market | |
---|---|---|---|
7D | 0.3% | -0.4% | 1.1% |
1Y | -33.6% | -29.0% | -20.4% |
Return vs Industry: 688739 underperformed the CN Biotechs industry which returned -29% over the past year.
Return vs Market: 688739 underperformed the CN Market which returned -20.4% over the past year.
Price Volatility
688739 volatility | |
---|---|
688739 Average Weekly Movement | 3.3% |
Biotechs Industry Average Movement | 5.8% |
Market Average Movement | 5.4% |
10% most volatile stocks in CN Market | 8.5% |
10% least volatile stocks in CN Market | 3.6% |
Stable Share Price: 688739 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688739's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2002 | 1,775 | Yu Mao | www.cdbio.cn |
Liaoning Chengda Biotechnology Co.,Ltd. a biotechnology company, engages in the research and development, production, and sales of vaccines for human use in China. It offers Chengda Suda human rabies and Chengda Libao Human Type B inactivated encephalitis vaccines.
Liaoning Chengda Biotechnology Co.,Ltd. Fundamentals Summary
688739 fundamental statistics | |
---|---|
Market cap | CN¥9.31b |
Earnings (TTM) | CN¥352.53m |
Revenue (TTM) | CN¥1.76b |
26.4x
P/E Ratio5.3x
P/S RatioIs 688739 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688739 income statement (TTM) | |
---|---|
Revenue | CN¥1.76b |
Cost of Revenue | CN¥373.38m |
Gross Profit | CN¥1.39b |
Other Expenses | CN¥1.03b |
Earnings | CN¥352.53m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.85 |
Gross Margin | 78.78% |
Net Profit Margin | 20.04% |
Debt/Equity Ratio | 0% |
How did 688739 perform over the long term?
See historical performance and comparison